A new study has found that too much sitting could increase the risk of cancer in women. Women in the study, reported in the journal Cancer Epidemiology, Biomarkers & Prevention, who sat more than six hours a day were at a higher risk of developing breast cancer, ovarian cancer and the blood cancer multiple myeloma compared with women who sat less than three hours a day.
The FDA has offered their approval on a new first-line treatment for metastatic lung cancer patients. The drug, called Iressa (gefitinib), is a kinase inhibitor that prevents the development of proteins that contribute to the creation of cancerous cells. The drug is specifically geared towards patients with a specific epidermal growth factor receptor (EGFR).
A new form of non-invasive pre-natal testing could indicate increased risk for maternal cancers, according to a new study from researchers at the Mother Infant Research Institute at Tufts Medical Center in Boston, Massachusetts. For the study the researchers reviewed the medical histories of eight mothers who underwent pre-natal testing and had irregular results.